Heidi Overton, President Trump’s nominee to head the Food and Drug Administration, faced intense scrutiny from Senate health committee members. Overton’s reluctance to openly contradict the President, including his dangerous claims about vaccines, raised eyebrows. Despite clear evidence, she staunchly defended the safety and efficacy of the MMR vaccine, even as she contradicted the President’s claims.

During the hearing, Senator Maggie Hassan directly challenged Overton with the question, ‘Is it possible for the President to be wrong? ’ Overton dodged the question, citing her role in working with the President. When pressed, she stuck to her position that the MMR vaccine is safe and effective, without addressing the President’s false claims.

The FDA is currently reviewing the safety of mifepristone, the abortion pill, despite extensive data showing its safety. Overton’s stance on abortion, as a clear opponent of the procedure, adds to the controversy surrounding her nomination. Her refusal to acknowledge the possibility of the President being wrong has sparked debate over her objectivity and the potential impact on public health.

The hearing highlighted the stark differences between scientific evidence and political rhetoric. As the nominee faces Senate confirmation, the question remains: can a political appointee truly be objective when their views align closely with controversial policies?